ChromaCon AG develops and sells laboratory and industrial equipment using innovative processes for purifying high-quality materials. Its main market is the biopharmaceutical sector. According to a statement, the patented processes enable the separation of impurities within a continuous process, attaining significantly higher yields while using far less column materials and buffer solutions.
ChromaCon AG has now been granted a loan guarantee by the Technology Fund, enabling ChromaCon to move forward with the development and commercialisation of its technology.
“The company is active in a field with a promising future with an innovative product which makes processes much quicker and more efficient,” said Simone Riedel Riley, managing director of the Technology Fund. “Using ChromaCon products is always worthwhile since it cuts both costs and CO2 emissions.”
The Technology Fund is an instrument of Swiss climate policy implemented by the Federal Office of the Environment. Its grants loan guarantees of up to CHF 3 million to small and medium-sized enterprises that are developing and marketing innovative environmentally friendly technologies. Back
